Article Versions Notes

Wu C-P, Lusvarghi S, Wang J-C, Hsiao S-H, Huang Y-H, Hung T-H, Ambudkar SV. The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences. 2020; 21(1):238. https://doi.org/10.3390/ijms21010238

Wu, Chung-Pu, Sabrina Lusvarghi, Jyun-Cheng Wang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung, and Suresh V. Ambudkar. 2020. "The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs" International Journal of Molecular Sciences 21, no. 1: 238. https://doi.org/10.3390/ijms21010238

Wu, C.-P., Lusvarghi, S., Wang, J.-C., Hsiao, S.-H., Huang, Y.-H., Hung, T.-H., & Ambudkar, S. V. (2020). The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences, 21(1), 238. https://doi.org/10.3390/ijms21010238